Temeka Alisha Gillespie is a Norfolk, Virginia based nurse practitioner. Active license number of Temeka Alisha Gillespie is 0024167054 in Virginia. Her current practice location is 7428 Tidewater Dr, Norfolk. Patients can reach her at 757-583-4000. Temeka Alisha Gillespie is NP and her NPI number (Unique professional ID assigned by NPPES) is 1871659235. Temeka Alisha Gillespie has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Temeka Alisha Gillespie speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1871659235
NPI Enumeration Date:
29 Dec, 2006
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Temeka Alisha Gillespie are as mentioned below.
License Number
Specialization
State
Status
0024167054
Virginia
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Temeka Alisha Gillespie 7428 Tidewater Dr, Norfolk, Virginia
Zip:
23505-3815
Phone Number:
757-583-4000
Patients can reach Temeka Alisha Gillespie at 7428 Tidewater Dr, Norfolk, Virginia or can call to book an appointment on 757-583-4000.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 April, 2025.